6
Oct
2026
PharmaMatch BV
Exhibitor at CPHI Milan 2026 stand 16H26, Finished Dosage & Formulation
About Us
Categories
-
Country/Region:Netherlands
-
On CPHI since:2015
-
Certificates:2
-
Employees:1 - 24
Company types
Primary activities
Event information
CPHI Milan 2026
-
6 Oct 2026 - 8 Oct 2026
-
Fiera Milano, Italy
-
Visit us at stand 16H26, Finished Dosage & Formulation
Products Featured at CPHI Milan 2026
-
Product Licensing for Partners
PharmaMatch represents companies from all over the world and we have always shown ourselves to be a reliable and trustworthy partner. Our sales team has an excellent network and they are continually assessing the market per product to find the best match. Our partners can expect our Sales team to appro... -
Product Regulatory Support
Our experienced regulatory team has a good understanding of the regulatory framework in every region. We’ve obtained registrations globally through our clients. Our team provides clients with quality dossiers compiled in accordance with the latest guidelines, which result in numerous successful registr... -
Product API Sourcing
PharmaMatch has an extensive network of API Active Pharmaceutical Ingredients (API) suppliers, ensuring our clients are matched with the right partner based on quality, price and regular supply. We can also provide third party audits or pre-audits for our clients to ensure the facilities are up to st... -
Product Contract Manufacturing Organisations
PharmaMatch has global contacts with contract manufacturing organisations (CMO’s). These state of the art CMOs are EU and/or US approved and follow the GMP standards of production. As clients demand high quality standards and a reliable supply chain with the best commercial conditions, the CMO par... -
Product Lab Services
Through one of our partners, we can provide comprehensive analytical support during the development of drug formulations. By combining innovative approaches, modern instruments and advanced knowledge in the field of analytical science we are able to achieve high performance in terms of selectivi...
